Sinovac Biotech Ltd
F:SVQ
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
| US |
|
Chevron Corp
NYSE:CVX
|
Energy
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
N/A
N/A
|
| Price Target |
|
We'll email you a reminder when the closing price reaches EUR.
Choose the stock you wish to monitor with a price alert.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Walmart Inc
NYSE:WMT
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
This alert will be permanently deleted.
Intrinsic Value
The intrinsic value of one
SVQ
stock under the Base Case scenario is
hidden
EUR.
Compared to the current market price of 5.58 EUR,
Sinovac Biotech Ltd
is
hidden
.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Valuation History
Sinovac Biotech Ltd
SVQ looks undervalued. But is it really? Some stocks live permanently below intrinsic value; one glance at Historical Valuation reveals if SVQ is one of them.
Learn how current stock valuations stack up against historical averages to gauge true investment potential.
Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.
Let our AI break down the key assumptions behind the intrinsic value calculation for Sinovac Biotech Ltd.
| FR |
|
Pharnext SCA
OTC:PNEXF
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
|
| US |
|
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
|
Fundamental Analysis
Select up to 3 indicators:
Select up to 3 indicators:
Revenue & Expenses Breakdown
Sinovac Biotech Ltd
Balance Sheet Decomposition
Sinovac Biotech Ltd
| Current Assets | 11.1B |
| Cash & Short-Term Investments | 10.6B |
| Receivables | 404.7m |
| Other Current Assets | 169m |
| Non-Current Assets | 1.7B |
| Long-Term Investments | 681.3m |
| PP&E | 950m |
| Intangibles | 7.8m |
| Other Non-Current Assets | 109.5m |
| Current Liabilities | 978.5m |
| Accounts Payable | 641.6m |
| Accrued Liabilities | 2.5m |
| Other Current Liabilities | 334.4m |
| Non-Current Liabilities | 3.3B |
| Long-Term Debt | 130.3m |
| Other Non-Current Liabilities | 3.1B |
Free Cash Flow Analysis
Sinovac Biotech Ltd
| USD | |
| Free Cash Flow | USD |
Earnings Waterfall
Sinovac Biotech Ltd
|
Revenue
|
429.2m
USD
|
|
Cost of Revenue
|
-33.9m
USD
|
|
Gross Profit
|
395.3m
USD
|
|
Operating Expenses
|
-757.3m
USD
|
|
Operating Income
|
-362m
USD
|
|
Other Expenses
|
231.3m
USD
|
|
Net Income
|
-130.7m
USD
|
SVQ Profitability Score
Profitability Due Diligence
Sinovac Biotech Ltd's profitability score is hidden . The higher the profitability score, the more profitable the company is.
Score
Sinovac Biotech Ltd's profitability score is hidden . The higher the profitability score, the more profitable the company is.
SVQ Solvency Score
Solvency Due Diligence
Sinovac Biotech Ltd's solvency score is hidden . The higher the solvency score, the more solvent the company is.
Score
Sinovac Biotech Ltd's solvency score is hidden . The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
SVQ Price Targets Summary
Sinovac Biotech Ltd
Dividends
Current shareholder yield for
SVA is
hidden
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one
SVQ
stock under the Base Case scenario is
hidden
EUR.
Compared to the current market price of 5.58 EUR,
Sinovac Biotech Ltd
is
hidden
.